Standard Contracts
INDEMNIFICATION AGREEMENTIndemnification Agreement • May 28th, 2021 • Cyteir Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS INDEMNIFICATION AGREEMENT (this “Agreement”) is made and entered into as of , 2021 between Cyteir Therapeutics, Inc., a Delaware corporation (the “Company”), and (“Indemnitee”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • May 28th, 2021 • Cyteir Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of May 25, 2021 (the “Effective Date”) by and between Cyteir Therapeutics, Inc. (the “Company”) and J. Paul Secrist (the “Executive”).
CYTEIR THERAPEUTICS, INC. RESTRICTED STOCK AGREEMENTRestricted Stock Agreement • May 28th, 2021 • Cyteir Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Restricted Stock Agreement (the “Agreement”) is entered into as of the effective date set forth on the signature page hereto (the “Effective Date”) by and between Cyteir Therapeutics, Inc., a Delaware corporation (the “Company”), and the person executing a counterpart signature page hereto (referred to herein as “Founder”).
CYTEIR THERAPEUTICS, INC. NON-QUALIFIED STOCK OPTION AGREEMENTNon-Qualified Stock Option Agreement • May 28th, 2021 • Cyteir Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This option satisfies in full all commitments that the Company has to the Optionee with respect to the issuance of stock, stock options or other equity securities. By signing below, the Optionee agrees to the terms and conditions set forth in this Agreement and in the Plan.
CYTEIR THERAPEUTICS, INC. SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT FEBRUARY 5, 2021Investors’ Rights Agreement • May 28th, 2021 • Cyteir Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Second Amended and Restated Investors’ Rights Agreement (the “Agreement”) is made as of February 5, 2021, by and among Cyteir Therapeutics, Inc., a Delaware corporation (the “Company”) and each of the individuals and entities listed on Schedule A (together with any subsequent investors, or transferees, who become parties hereto pursuant to Subsection 6.9 below, the “Investors”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • May 28th, 2021 • Cyteir Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Amended and Restated Employment Agreement (the “Agreement”), dated as of May 25, 2021 (the “Effective Date”), is by and between Cyteir Therapeutics, Inc., a Delaware corporation (the “Company”) and Markus Renschler (the “Executive”).
CYTEIR THERAPEUTICS, INC. INCENTIVE STOCK OPTION AGREEMENTIncentive Stock Option Agreement • May 28th, 2021 • Cyteir Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This option satisfies in full all commitments that the Company has to the Optionee with respect to the issuance of stock, stock options or other equity securities. By signing below, the Optionee agrees to the terms and conditions set forth in this Agreement and in the Plan.
